Successful allogeneic cryopreserved marrow transplantation
- PMID: 2645697
- DOI: 10.1046/j.1537-2995.1989.29289146840.x
Successful allogeneic cryopreserved marrow transplantation
Abstract
Cryopreservation has been used extensively in autologous marrow transplantation (BMT), but there has been limited use in allogeneic BMT. We describe here 6 cases of successful engraftment following allogeneic BMT with cryopreserved marrow. Patients suffered from Wiscott-Aldrich syndrome, osteopetrosis, aplastic anemia, and acute lymphocytic, acute non-lymphocytic, and chronic myelogenous leukemia, and ranged in age from 5 mos to 35 yrs. Marrow was collected using standard techniques. In one case T-cells were removed to prevent graft-vs-host disease. Marrow was frozen for a variety of reasons. Buffy coat cells were frozen at controlled rate in 10% DMSO, and stored in liquid nitrogen for 6 to 49 d. Engraftment (WBC greater than 1000/uL x 3 d) occurred from 13 to 37 d post BMT. In 4 of 4 cases in which data are available, donor origin of engraftment was documented, 1 with cytogenetics, 2 with red cell typing, and 4 with restriction fragment length polymorphisms. 3 patients are alive and well 21, 21, and 42 months post BMT. These results suggest frozen marrow can be successfully used for allogeneic BMT.
Similar articles
-
Long-term follow-up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation.Br J Haematol. 1997 Feb;96(2):382-6. doi: 10.1046/j.1365-2141.1997.d01-2032.x. Br J Haematol. 1997. PMID: 9029030
-
Donor origin of hematopoiesis after a case of allogeneic transplantation with cryopreserved marrow.Haematologica. 1993 Nov-Dec;78(6):414-5. Haematologica. 1993. PMID: 8175039
-
Use of cryopreserved bone marrow in unrelated allogeneic transplantation.Bone Marrow Transplant. 1996 Feb;17(2):197-9. Bone Marrow Transplant. 1996. PMID: 8640166 Review.
-
[Allogeneic cryopreserved marrow transplantation in a patient with chronic myelogenous leukemia].Rinsho Ketsueki. 1994 Mar;35(3):304-8. Rinsho Ketsueki. 1994. PMID: 8158854 Japanese.
-
Allogeneic bone marrow transplantation in the treatment of hematologic diseases.Clin Pharm. 1985 Mar-Apr;4(2):149-60. Clin Pharm. 1985. PMID: 3886273 Review.
Cited by
-
Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.Stem Cells. 2016 Sep;34(9):2429-42. doi: 10.1002/stem.2415. Epub 2016 Jul 4. Stem Cells. 2016. PMID: 27299362 Free PMC article.
-
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP).Bone Marrow Transplant. 2023 Dec;58(12):1348-1356. doi: 10.1038/s41409-023-02099-w. Epub 2023 Sep 6. Bone Marrow Transplant. 2023. PMID: 37673982 Review.
-
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.Biol Blood Marrow Transplant. 2020 Jul;26(7):1312-1317. doi: 10.1016/j.bbmt.2020.04.001. Epub 2020 Apr 10. Biol Blood Marrow Transplant. 2020. PMID: 32283185 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical